4.6 Editorial Material

Common and rare genetic variants and risk of CHD

Journal

NATURE REVIEWS CARDIOLOGY
Volume 14, Issue 2, Pages 73-74

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nrcardio.2016.209

Keywords

-

Funding

  1. National Institute for Health Research Academic Clinical Fellowship
  2. National Institute for Health Research, University College London and Hospitals Biomedical Research Centre
  3. British Heart Foundation [PG08/008]
  4. British Heart Foundation [RG/08/008/25291] Funding Source: researchfish
  5. National Institute for Health Research [ACF-2015-21-003] Funding Source: researchfish

Ask authors/readers for more resources

Much of the progress in cardiovascular genetics in 2016 has been driven by next-generation sequencing studies, and the clinical utility of knowing an individual's genotype for predicting their risk of cardiovascular disease is gaining credibility, both for monogenic and polygenic disorders. Additionally, phenotype data are increasingly abundant, although databases linking genotype with clinically relevant phenotypes require optimization.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Nutrition & Dietetics

Alcohol consumption in relation to carotid subclinical atherosclerosis and its progression: results from a European longitudinal multicentre study

Federica Laguzzi, Damiano Baldassarre, Fabrizio Veglia, Rona J. Strawbridge, Steve E. Humphries, Rainer Rauramaa, Andries J. Smit, Philippe Giral, Angela Silveira, Elena Tremoli, Anders Hamsten, Ulf de Faire, Paolo Frumento, Karin Leander

Summary: Based on data from a European multicentre study, this research found an inverse association between moderate alcohol consumption and carotid subclinical atherosclerosis and its 30-month progression. The relationship between alcohol consumption and C-IMT appears to be linear.

EUROPEAN JOURNAL OF NUTRITION (2021)

Article Cardiac & Cardiovascular Systems

Metabolic Dysregulation of the Lysophospholipid/Autotaxin Axis in the Chromosome 9p21 Gene SNP rs10757274

Sven W. Meckelmann, Jade Hawksworth, Daniel A. White, Robert Andrews, Patricia R. S. Rodrigues, Anne O'Connor, Jorge Alvarez-Jarreta, Victoria Tyrrell, Christine Hinz, You Zhou, Julie Williams, Maceler Aldrovandi, William John Watkins, Adam Engler, David A. Slatter, Stuart Allen, Jay Acharya, Jacquie Mitchell, Jackie Cooper, Junken Aoki, Kuniyuki Kano, Steve Humphries, Valerie O'Donnell, Valentina Lo Sardo

CIRCULATION-GENOMIC AND PRECISION MEDICINE (2020)

Review Biochemistry & Molecular Biology

Non-HDL or LDL cholesterol in heterozygous familial hypercholesterolaemia: findings of the Simon Broome Register

Handrean Soran, Jackie A. Cooper, Paul N. Durrington, Nigel Capps, Ian Fw McDowell, Steve E. Humphries, Andrew Neil

CURRENT OPINION IN LIPIDOLOGY (2020)

Review Pediatrics

Management of familial hypercholesterolaemia in childhood

Uma Ramaswami, Steve E. Humphries

CURRENT OPINION IN PEDIATRICS (2020)

Article Medical Laboratory Technology

Establishing reference intervals for triglyceride-containing lipoprotein subfraction metabolites measured using nuclear magnetic resonance spectroscopy in a UK population

Roshni Joshi, Goya Wannamethee, Jorgen Engmann, Tom Gaunt, Deborah A. Lawlor, Jackie Price, Olia Papacosta, Tina Shah, Therese Tillin, Peter Whincup, Nishi Chaturvedi, Mika Kivimaki, Diana Kuh, Meena Kumari, Alun D. Hughes, Juan P. Casas, Steve E. Humphries, Aroon D. Hingorani, A. Floriaan Schmidt

Summary: This study measured 14 triglyceride-containing lipoprotein subfraction metabolites using nuclear magnetic resonance in a general population sample, establishing reference interval ranges. The results showed that triglyceride subfraction concentrations increased with age and body mass index, were higher in smokers, and in individuals with cardiovascular disease or type 2 diabetes. These findings emphasize the importance of appropriate reference interval ranges for clinical decision making regarding the role of triglycerides in cardiovascular disease.

ANNALS OF CLINICAL BIOCHEMISTRY (2021)

Article Cardiac & Cardiovascular Systems

Sex differences in cardiovascular morbidity associated with familial hypercholesterolaemia: A retrospective cohort study of the UK Simon Broome register linked to national hospital records

Barbara Iyen, Nadeem Qureshi, Stephen Weng, Paul Roderick, Joe Kai, Nigel Capps, Paul N. Durrington, Ian F. W. McDowell, Handrean Soran, Andrew Neil, Steve E. Humphries

ATHEROSCLEROSIS (2020)

Article Multidisciplinary Sciences

The overlap of genetic susceptibility to schizophrenia and cardiometabolic disease can be used to identify metabolically different groups of individuals

Rona J. Strawbridge, Keira J. A. Johnston, Mark E. S. Bailey, Damiano Baldassarre, Breda Cullen, Per Eriksson, Ulf deFaire, Amy Ferguson, Bruna Gigante, Philippe Giral, Nicholas Graham, Anders Hamsten, Steve E. Humphries, Sudhir Kurl, Donald M. Lyall, Laura M. Lyall, Jill P. Pell, Matteo Pirro, Kai Savonen, Andries J. Smit, Elena Tremoli, Tomi-Pekka Tomainen, Fabrizio Veglia, Joey Ward, Bengt Sennblad, Daniel J. Smith

Summary: This study identified genetic associations between psychiatric disorders and cardiometabolic diseases in individuals of European ancestry, leading to the identification of sub-groups with distinct metabolic profiles. These findings were consistent across different samples, indicating potential implications for personalized approaches to managing cardiometabolic risks in individuals with severe mental illness.

SCIENTIFIC REPORTS (2021)

Article Cardiac & Cardiovascular Systems

Comparison of the mutation spectrum and association with pre and post treatment lipid measures of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries

Marta Futema, Uma Ramaswami, Lukas Tichy, Martin P. Bogsrud, Kirsten B. Holven, Jeanine Roeters van Lennep, Albert Wiegman, Olivier S. Descamps, Anne De Leener, Elodie Fastre, Michal Vrablik, Tomas Freiberger, Harald Esterbauer, Hans Dieplinger, Susanne Greber-Platzer, Ana M. Medeiros, Mafalda Bourbon, Vasiliki Mollaki, Euridiki Drogari, Steve E. Humphries

Summary: The most common cause of familial hypercholesterolaemia in children from eight European countries was found to be LDLR mutation, with significant variations in the prevalence of APOB p.(Arg3527Gln) mutation across different countries. LDLR-FH was associated with higher concentrations of LDL-C and a family history of coronary heart disease compared to APOB-FH in children.

ATHEROSCLEROSIS (2021)

Article Biochemistry & Molecular Biology

Genome-wide association study of circulating interleukin 6 levels identifies novel loci

Tarunveer S. Ahluwalia, Bram P. Prins, Mohammadreza Abdollahi, Nicola J. Armstrong, Stella Aslibekyan, Lisa Bain, Barbara Jefferis, Jens Baumert, Marian Beekman, Yoav Ben-Shlomo, Joshua C. Bis, Braxton D. Mitchell, Eco de Geus, Graciela E. Delgado, Diana Marek, Joel Eriksson, Eero Kajantie, Stavroula Kanoni, John P. Kemp, Chen Lu, Riccardo E. Marioni, Stela McLachlan, Yuri Milaneschi, Ilja M. Nolte, Alexandros M. Petrelis, Eleonora Porcu, Maria Sabater-Lleal, Elnaz Naderi, Ilkka Seppala, Tina Shah, Gaurav Singhal, Marie Standl, Alexander Teumer, Anbupalam Thalamuthu, Elisabeth Thiering, Stella Trompet, Christie M. Ballantyne, Emelia J. Benjamin, Juan P. Casas, Catherine Toben, George Dedoussis, Joris Deelen, Peter Durda, Jorgen Engmann, Mary F. Feitosa, Harald Grallert, Ann Hammarstedt, Sarah E. Harris, Georg Homuth, Jouke-Jan Hottenga, Sirpa Jalkanen, Yalda Jamshidi, Magdalene C. Jawahar, Tine Jess, Mika Kivimaki, Marcus E. Kleber, Jari Lahti, Yongmei Liu, Pedro Marques-Vidal, Dan Mellstrom, Simon P. Mooijaart, Martina Muller-Nurasyid, Brenda Penninx, Joana A. Revez, Peter Rossing, Katri Raikkonen, Naveed Sattar, Hubert Scharnagl, Bengt Sennblad, Angela Silveira, Beate St Pourcain, Nicholas J. Timpson, Julian Trollor, Jenny van Dongen, Diana Van Heemst, Sophie Visvikis-Siest, Peter Vollenweider, Uwe Volker, Melanie Waldenberger, Gonneke Willemsen, Delilah Zabaneh, Richard W. Morris, Donna K. Arnett, Bernhard T. Baune, Dorret Boomsma, Yen-Pei C. Chang, Ian J. Deary, Panos Deloukas, Johan G. Eriksson, David M. Evans, Manuel A. Ferreira, Tom Gaunt, Vilmundur Gudnason, Anders Hamsten, Joachim Heinrich, Aroon Hingorani, Steve E. Humphries, J. Wouter Jukema, Wolfgang Koenig, Meena Kumari, Zoltan Kutalik, Deborah A. Lawlor, Terho Lehtimaki, Winfried Marz, Karen A. Mather, Silvia Naitza, Matthias Nauck, Claes Ohlsson, Jackie F. Price, Olli Raitakari, Ken Rice, Perminder S. Sachdev, Eline Slagboom, Thorkild I. A. Sorensen, Tim Spector, David Stacey, Maria G. Stathopoulou, Toshiko Tanaka, S. Goya Wannamethee, Peter Whincup, Jerome Rotter, Abbas Dehghan, Eric Boerwinkle, Bruce M. Psaty, Harold Snieder, Behrooz Z. Alizadeh

Summary: This study identified novel genetic loci influencing circulating IL-6 levels, uncovering new immunological and inflammatory pathways that may impact the pathobiology of IL-6.

HUMAN MOLECULAR GENETICS (2021)

Review Cardiac & Cardiovascular Systems

Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics

Daniel Swerdlow, David A. Rider, Arash Yavari, Marie Wikstrom Lindholm, Giles Campion, Steven E. Nissen

Summary: While lipid- and lipoprotein-modifying therapies have shown effectiveness in reducing cardiovascular disease risk, no specific therapy targeting lipoprotein(a) (Lp(a)) has been proven to be successful. Lp(a) is a genetically determined risk factor for various cardiovascular diseases, and reducing its levels through a safe and effective therapy has become a priority. N-acetylgalactosamine-conjugated gene silencing therapeutics, such as small interfering RNA (siRNA), offer a promising approach for lowering Lp(a) with few doses per year. This review evaluates the role of Lp(a) in cardiovascular disease, the effectiveness of current lipid-modifying therapies, and the potential of siRNA therapeutics in treating and preventing Lp(a)-related diseases.

CARDIOVASCULAR RESEARCH (2022)

Article Multidisciplinary Sciences

Intake of food rich in saturated fat in relation to subclinical atherosclerosis and potential modulating effects from single genetic variants

Federica Laguzzi, Buamina Maitusong, Rona J. Strawbridge, Damiano Baldassarre, Fabrizio Veglia, Steve E. Humphries, Rainer Rauramaa, Sudhir Kurl, Andries J. Smit, Philippe Giral, Angela Silveira, Elena Tremoli, Anders Hamsten, Ulf de Faire, Bruna Gigante, Karin Leander

Summary: The study aimed to investigate the relationship between intake of saturated fats and subclinical atherosclerosis, as well as the potential influence of genetic variants. Results showed an association between high intake of saturated fats and C-IMT thickness, but this association was no longer significant in multivariate analysis. There was no clear association between high intake of saturated fats and risk of atherosclerotic progression. Additionally, no significant genetic-dietary fat interactions were identified in relation to risk of subclinical atherosclerosis.

SCIENTIFIC REPORTS (2021)

Article Cardiac & Cardiovascular Systems

Association Between Uric Acid, Carotid Intima-Media Thickness, and Cardiovascular Events: Prospective Results From the IMPROVE Study

Massimo R. Mannarino, Matteo Pirro, Bruna Gigante, Kai Savonen, Sudhir Kurl, Philippe Giral, Andries Smit, Fabrizio Veglia, Elena Tremoli, Damiano Baldassarre

Summary: The study found a U-shaped association between SUA levels and VEs in men at moderate-to-high CVD risk, with both low and high SUA levels being associated with an increased risk of VEs. Elevated SUA levels were also independently associated with cIMT progression in men. However, no significant associations were found in women between SUA levels, CVD end points, and cIMT progression.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Article Biotechnology & Applied Microbiology

Lack of Association of LPA Gene Polymorphisms with Coronary Artery Disease in Pakistani Subjects

Saleem Ullah Shahid, N. A. Shabana, Steve Humphries

Summary: Coronary artery disease is the leading cause of death worldwide, with Pakistan facing a high epidemic. While genetic markers have been associated with CAD, a study on LPA gene SNPs in Pakistani subjects showed that they do not significantly contribute to CAD progression.

DISEASE MARKERS (2021)

Article Cardiac & Cardiovascular Systems

Case-finding and genetic testing for familial hypercholesterolaemia in primary care

Nadeem Qureshi, Ralph Kwame Akyea, Brittany Dutton, Steve E. Humphries, Hasidah Abdul Hamid, Laura Condon, Stephen F. Weng, Joe Kai

Summary: By utilizing electronic case-finding and genetic testing in primary care, this intervention study was able to improve the identification of patients at risk of familial hypercholesterolaemia and target them for specialist assessment. The results showed that patients with FH-causing genetic variants had higher total cholesterol and low-density lipoprotein-cholesterol levels compared to those with other genetic test results.

HEART (2021)

Article Cardiac & Cardiovascular Systems

Comparing the performance of the novel FAMCAT algorithms and established case-finding criteria for familial hypercholesterolaemia in primary care

Nadeem Qureshi, Ralph K. Akyea, Brittany Dutton, Jo Leonardi-Bee, Steve E. Humphries, Stephen Weng, Joe Kai

Summary: A novel case-finding algorithm, FAMCAT 2, shows better performance in detecting genetically confirmed FH in the general population compared to other established criteria, without the need for prior clinical review.

OPEN HEART (2021)

No Data Available